Neurol. praxi. 2025;26(4):312-317 | DOI: 10.36290/neu.2025.036

The role of gut dysbiosis in the pathogenesis of neurodegenerative diseases

Petr Roudenský, MSc., MSc.
The University of Sheffield: Neuroscience - Neurodegeneration, Velká Británie

The gut microbiome plays a crucial role in the regulation of the central nervous system through the gut-brain axis, and especially in the last decade, new findings have emerged suggesting a key role of its imbalance - dysbiosis - in the pathogenesis of a number of neurodegenerative diseases, particularly Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Underlying mechanisms include increased intestinal permeability, neuroinflammation, microbiota metabolites and disruption of neurotransmitter signalling. Experimental studies suggest that modulation of the gut microbiome, for example through fecal microbial transplantation, may influence the clinical course of these diseases. Further and more rigorous research is needed to elucidate the causality and potential of therapeutic interventions.

Keywords: neurodegeneration, gut microbiome, mikrobiota, dysbiosis, gut-brain axis.

Received: March 5, 2025; Revised: March 5, 2025; Accepted: April 10, 2025; Prepublished online: April 10, 2025; Published: September 29, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Roudenský P. The role of gut dysbiosis in the pathogenesis of neurodegenerative diseases. Neurol. praxi. 2025;26(4):312-317. doi: 10.36290/neu.2025.036.
Download citation

References

  1. Boddy SL, Giovannelli I, Sassani M, et al. The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS). BMC Medicine. 2021;19(1). doi:https://doi.org/10.1186/s12916-020-01885-3. Go to original source... Go to PubMed...
  2. Bruggeman A, Vandendriessche C, Hamerlinck H, et al. Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson's disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial. EClinicalMedicine. 2024;71:102563-102563. doi:https://doi.org/10.1016/j.eclinm.2024.102563. Go to original source... Go to PubMed...
  3. Ciarlo E, Heinonen T, Herderschee J, et al. Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and fungal infections in vivo. Scientific Reports. 2016;6(1). doi:https://doi.org/10.1038/srep37944. Go to original source... Go to PubMed...
  4. Cryan JF, Dinan TG. Mind-altering microorganisms: the Impact of the Gut Microbiota on Brain and Behaviour. Nature Reviews Neuroscience. 2012;13(10):701-712. doi:https://doi.org/10.1038/nrn3346. Go to original source... Go to PubMed...
  5. Erny D, Hrabě de Angelis AL, Jaitin D, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nature Neuroscience. 2015;18(7):965-977. doi:https://doi.org/10.1038/nn.4030. Go to original source... Go to PubMed...
  6. Ferreiro A, Choi J, Ryou J, et al. Gut microbiome composition may be an indicator of preclinical Alzheimer's disease. Science Translational Medicine. 2023;15(700). doi:https://doi.org/10.1126/scitranslmed.abo2984. Go to original source... Go to PubMed...
  7. Huang Y, Wu J, Zhang H, et al. The gut microbiome modulates the transformation of microglial subtypes. Molecular Psychiatry. Published online March 13, 2023:1-11. doi:https://doi.org/10.1038/s41380-023-02017-y. Go to original source...
  8. Leclercq S, Mian FM, Stanisz AM, et al. Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior. Nature Communications. 2017;8(1):1-12. doi:https://doi.org/10.1038/ncomms15062. Go to original source... Go to PubMed...
  9. Li T, Chen H, Xu B, et al. Deciphering the interplay between LPS/TLR4 pathways, neurotransmitter, and deltamethrin-induced depressive-like behavior: Perspectives from the gut-brain axis. Pesticide Biochemistry and Physiology. 2023;197:105697-105697. doi:https://doi.org/10.1016/j.pestbp.2023.105697. Go to original source... Go to PubMed...
  10. Liu L, Yi Y, Yan R, et al. Impact of age-related gut microbiota dysbiosis and reduced short-chain fatty acids on the autonomic nervous system and atrial fibrillation in rats. Frontiers in Cardiovascular Medicine. 2024;11. doi:https://doi.org/10.3389/fcvm.2024.1394929. Go to original source... Go to PubMed...
  11. Loh JS, Mak WQ, Tan LKS, et al. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduction and Targeted Therapy. 2024;9(1):1-53. doi:https://doi.org/10.1038/s41392-024-01743-1. Go to original source... Go to PubMed...
  12. Lu G, Wen Q, Cui B, et al. Washed microbiota transplantation stopped the deterioration of amyotrophic lateral sclerosis: The first case report and narrative review. Journal of Biomedical Research. 2022;37(1):69-76. doi:https://doi.org/10.7555/JBR.36.20220088. Go to original source... Go to PubMed...
  13. Nie S, Wang J, Deng Y, et al. Inflammatory microbes and genes as potential biomarkers of Parkinson's disease. npj Biofilms and Microbiomes. 2022;8(1). doi:https://doi.org/10.1038/s41522-022-00367-z. Go to original source... Go to PubMed...
  14. Noor Eddin A, Alfuwais M, Noor Eddin R, et al. Gut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives. Nutrients. 2024;16(5):590. doi:https://doi.org/10.3390/nu16050590. Go to original source...
  15. Park SH, Lee JH, Kim JS, et al. Fecal microbiota transplantation can improve cognition in patients with cognitive decline and Clostridioides difficile infection. Aging. 2022;14(16):6449-6466. doi:https://doi.org/10.18632/aging.204230. Go to original source... Go to PubMed...
  16. Qian Y, Yang X, Xu S, et al. Alteration of the fecal microbiota in Chinese patients with Parkinson's disease. Brain, Behavior, and Immunity. 2018;70:194-202. doi:https://doi.org/10.1016/j.bbi.2018.02.016. Go to original source... Go to PubMed...
  17. Rojas-Valverde D, Bonilla DA, Luis Mario Gómez-Miranda, et al. Examining the Interaction between Exercise, Gut Microbiota, and Neurodegeneration: Future Research Directions. Biomedicines. 2023;11(8):2267-2267. doi:https://doi.org/10.3390/biomedicines11082267. Go to original source...
  18. Rowin J, Xia Y, Jung B, Sun J. Gut inflammation and dysbiosis in human motor neuron disease. Physiological reports. 2017;5(18):e13443. doi:https://doi.org/10.14814/phy2.13443. Go to original source... Go to PubMed...
  19. Syeda Elezeh Sabahat, Saqib M, Talib M, Shaikh TG, et al. Bile acid modulation by gut microbiota: A bridge to understanding cognitive health. Annals of Medicine and Surgery. 2024;86(9):5410-5415. doi:https://doi.org/10.1097/ms9.0000000000002433. Go to original source... Go to PubMed...
  20. Scheperjans F, Levo R, Bosch B, et al. Fecal Microbiota Transplantation for Treatment of Parkinson Disease. JAMA Neurology. 2024;81(9):925. doi:https://doi.org/10.1001/jamaneurol.2024.2305. Go to original source...
  21. Toepfer C, Folwaczny A, Klauser, RLM. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 2000;1(1):15-19. doi:https://doi.org/10.1080/146608299300079484. Go to original source... Go to PubMed...
  22. Track NS. The gastrointestinal endocrine system. Can Med Assoc J. 1980;122(3):287-292.
  23. Vineis P, Robinson O, Chadeau-Hyam M, et al. What is new in the exposome? Environment International. 2020;143:105887. doi:https://doi.org/10.1016/j.envint.2020.105887. Go to original source... Go to PubMed...
  24. Yan J, Chen H, Zhang Y, et al. Fecal microbiota transplantation significantly improved respiratory failure of amyotrophic lateral sclerosis. Gut Microbes. 2024;16(1). doi:https://doi.org/10.1080/19490976.2024.2353396. Go to original source... Go to PubMed...
  25. Zhai CD, Zheng J, An BC, et al. Intestinal microbiota composition in patients with amyotrophic lateral sclerosis. Chinese Medical Journal. 2019;132(15):1815-1822. doi:https://doi.org/10.1097/cm9.0000000000000351. Go to original source...
  26. Zhang H, Chen Y, Wang Z, et al. Implications of Gut Microbiota in Neurodegenerative Diseases. Frontiers in Immunology. 2022;13. doi:https://doi.org/10.3389/fimmu.2022.785644. Go to original source...
  27. Zhang L, Zhuang Z, Zhang G, et al. Assessment of bidirectional relationships between 98 genera of the human gut microbiota and amyotrophic lateral sclerosis: a 2-sample Mendelian randomization study. BMC Neurology. 2022;22(1). doi:https://doi.org/10.1186/s12883-021-02522-z. Go to original source... Go to PubMed...
  28. Zhang R, Miller RG, Gascon R, et al. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). Journal of Neuroimmunology. 2009;206(1):121-124. doi:https://doi.org/10.1016/j.jneuroim.2008.09.017. Go to original source... Go to PubMed...
  29. Zhang Y, Ogbu D, Garrett S, et al. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis. Gut Microbes. 2021;13(1). doi:https://doi.org/10.1080/19490976.2021.1996848. Go to original source... Go to PubMed...
  30. Zhao J, Bi W, Xiao S, et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Scientific Reports. 2019;9(1). doi:https://doi.org/10.1038/s41598-019-42286-8. Go to original source... Go to PubMed...
  31. Zhao Y, Cong L, Jaber V, Lukiw WJ. Microbiome-Derived Lipopolysaccharide Enriched in the Perinuclear Region of Alzheimer's Disease Brain. Frontiers in Immunology. 2017;8. doi:https://doi.org/10.3389/fimmu.2017.01064. Go to original source...
  32. Zhao Z, Chen J, Zhao D, et al. Microbial biomarker discovery in Parkinson's disease through a network-based approach. npj Parkinson s Disease. 2024;10(1). doi:https://doi.org/10.1038/s41531-024-00802-2. Go to original source...
  33. Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Research. 2020;30(6):492-506. doi:https://doi.org/10.1038/s41422-020-0332-7. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.